Oncogenic and drug-sensitive RET mutations in human epithelial ovarian cancerLuyao Guan(Obstetrics and Gynecology Hospital of Fudan University), Yuan Lu(Obstetrics and Gynecology Hospital of Fudan University)Journal of Experimental & Clinical Cancer ResearchMarch 23, 202010.1186/s13046-020-01557-3Cited by 10SaveCiteExport RISWatch citationsRelated PapersOncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression|Carcinogenesis|2019|25<scp>HIF</scp>‐1<i>α</i> binding to <scp>AEG</scp>‐1 promoter induced upregulated <scp>AEG</scp>‐1 expression associated with metastasis in ovarian cancer|Cancer Medicine|2017|19